{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T12:30:32Z","timestamp":1787574632086,"version":"build-2736575974"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T00:00:00Z","timestamp":1781481600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":70,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Stem Cell Res Ther"],"DOI":"10.1186\/s13287-026-05115-0","type":"journal-article","created":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T09:45:14Z","timestamp":1781516714000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["MSCs\/EVs-based therapy targeting DAD: research progress and future perspectives from ARDS and COVID-19 to RP-ILD"],"prefix":"10.1186","volume":"17","author":[{"given":"Xiangzhen","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinlun","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,15]]},"reference":[{"issue":"10300","key":"5115_CR1","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1016\/S0140-6736(21)00439-6","volume":"398","author":"NJ Meyer","year":"2021","unstructured":"Meyer NJ, Gattinoni L, Calfee CS. Acute respiratory distress syndrome. Lancet. 2021;398(10300):622\u201337. https:\/\/doi.org\/10.1016\/S0140-6736(21)00439-6.","journal-title":"Lancet"},{"issue":"6","key":"5115_CR2","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1513\/AnnalsATS.201609-728PS","volume":"14","author":"P Cardinal-Fern\u00e1ndez","year":"2017","unstructured":"Cardinal-Fern\u00e1ndez P, Lorente JA, Ball\u00e9n-Barrag\u00e1n A, Matute-Bello G. Acute respiratory distress syndrome and diffuse alveolar damage. New insights on a complex relationship. Ann Am Thorac Soc. 2017;14(6):844\u201350. https:\/\/doi.org\/10.1513\/AnnalsATS.201609-728PS.","journal-title":"Ann Am Thorac Soc"},{"key":"5115_CR3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200005043421806","author":"LB Ware","year":"2000","unstructured":"Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med. 2000. https:\/\/doi.org\/10.1056\/NEJM200005043421806.","journal-title":"N Engl J Med"},{"issue":"25","key":"5115_CR4","doi-asserted-by":"publisher","first-page":"2451","DOI":"10.1056\/NEJMcp2009575","volume":"383","author":"DA Berlin","year":"2020","unstructured":"Berlin DA, Gulick RM, Martinez FJ. Severe covid-19. Solomon CG. editor N Engl J Med. 2020;383(25):2451\u201360. https:\/\/doi.org\/10.1056\/NEJMcp2009575.","journal-title":"editor N Engl J Med"},{"issue":"1","key":"5115_CR5","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/s41584-023-01054-9","volume":"20","author":"X Lu","year":"2024","unstructured":"Lu X, Peng Q, Wang G. Anti-MDA5 antibody-positive dermatomyositis: pathogenesis and clinical progress. Nat Rev Rheumatol. 2024;20(1):48\u201362. https:\/\/doi.org\/10.1038\/s41584-023-01054-9.","journal-title":"Nat Rev Rheumatol"},{"issue":"7","key":"5115_CR6","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1164\/rccm.201302-0385ED","volume":"18787","author":"BT Thompson","year":"2013","unstructured":"Thompson BT, Matthay MA. The Berlin definition of ARDS versus pathological evidence of diffuse alveolar damage. Am J Respir Crit Care Med. 2013;18787(7):675\u20136. https:\/\/doi.org\/10.1164\/rccm.201302-0385ED.","journal-title":"Am J Respir Crit Care Med"},{"issue":"8","key":"5115_CR7","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1001\/jama.2016.0291","volume":"315","author":"G Bellani","year":"2016","unstructured":"Bellani G, Laffey JG, Pham T, Fan E, Brochard L, Esteban A, et al. Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. JAMA. 2016;315(8):788. https:\/\/doi.org\/10.1001\/jama.2016.0291.","journal-title":"JAMA"},{"issue":"1","key":"5115_CR8","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s00134-020-06294-x","volume":"47","author":"COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators","year":"2021","unstructured":"COVID-ICU Group on behalf of the REVA Network and the COVID-ICU Investigators. Clinical characteristics and day-90 outcomes of 4244 critically ill adults with COVID-19: a prospective cohort study. Intensive Care Med. 2021;47(1):60\u201373. https:\/\/doi.org\/10.1007\/s00134-020-06294-x.","journal-title":"Intensive Care Med"},{"issue":"163","key":"5115_CR9","doi-asserted-by":"publisher","first-page":"210185","DOI":"10.1183\/16000617.0185-2021","volume":"31","author":"D Montani","year":"2022","unstructured":"Montani D, Savale L, Noel N, Meyrignac O, Colle R, Gasnier M, et al. Post-acute COVID-19 syndrome. Eur Respir Rev. 2022;31(163):210185. https:\/\/doi.org\/10.1183\/16000617.0185-2021.","journal-title":"Eur Respir Rev"},{"issue":"1","key":"5115_CR10","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13613-018-0433-3","volume":"8","author":"C Vuillard","year":"2018","unstructured":"Vuillard C, Pineton De Chambrun M, De Prost N, Gu\u00e9rin C, Schmidt M, Dargent A, et al. Clinical features and outcome of patients with acute respiratory failure revealing anti-synthetase or anti-MDA-5 dermato-pulmonary syndrome: a French multicenter retrospective study. Ann Intensive Care. 2018;8(1):87. https:\/\/doi.org\/10.1186\/s13613-018-0433-3.","journal-title":"Ann Intensive Care"},{"issue":"3","key":"5115_CR11","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1093\/rheumatology\/keac450","volume":"62","author":"H You","year":"2023","unstructured":"You H, Wang L, Wang J, Lv C, Xu L, Yuan F, et al. Time-dependent changes in RPILD and mortality risk in anti-MDA5\u2009+\u2009DM patients: a cohort study of 272 cases in China. Rheumatology. 2023;62(3):1216\u201326. https:\/\/doi.org\/10.1093\/rheumatology\/keac450.","journal-title":"Rheumatology"},{"issue":"4","key":"5115_CR12","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.semarthrit.2020.03.007","volume":"50","author":"F Romero-Bueno","year":"2020","unstructured":"Romero-Bueno F, Diaz Del Campo P, Trallero-Aragu\u00e1s E, Ruiz-Rodr\u00edguez JC, Castellvi I, Rodriguez-Nieto MJ, et al. Recommendations for the treatment of anti-melanoma differentiation-associated gene 5-positive dermatomyositis-associated rapidly progressive interstitial lung disease. Semin Arthritis Rheum. 2020;50(4):776\u201390. https:\/\/doi.org\/10.1016\/j.semarthrit.2020.03.007.","journal-title":"Semin Arthritis Rheum"},{"key":"5115_CR13","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathol-011110-130158","author":"MA Matthay","year":"2011","unstructured":"Matthay MA, Zemans RL. The acute respiratory distress syndrome_ pathogenesis and treatment. Annu Rev Pathol. 2011. https:\/\/doi.org\/10.1146\/annurev-pathol-011110-130158.","journal-title":"Annu Rev Pathol"},{"issue":"1","key":"5115_CR14","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.stem.2009.06.013","volume":"5","author":"M Pittenger","year":"2009","unstructured":"Pittenger M. Sleuthing the source of regeneration by MSCs. Cell Stem Cell. 2009;5(1):8\u201310. https:\/\/doi.org\/10.1016\/j.stem.2009.06.013.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"5115_CR15","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/1478-811X-9-12","volume":"9","author":"R Hass","year":"2011","unstructured":"Hass R, Kasper C, B\u00f6hm S, Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal. 2011;9(1):12. https:\/\/doi.org\/10.1186\/1478-811X-9-12.","journal-title":"Cell Commun Signal"},{"key":"5115_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9472","author":"DG Phinney","year":"2015","unstructured":"Phinney DG, Giuseppe MD, Njah J. Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs. Nat Commun. 2015. https:\/\/doi.org\/10.1038\/ncomms9472.","journal-title":"Nat Commun"},{"issue":"10","key":"5115_CR17","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/S1473-3099(20)30434-5","volume":"20","author":"L Carsana","year":"2020","unstructured":"Carsana L, Sonzogni A, Nasr A, Rossi RS, Pellegrinelli A, Zerbi P, et al. Pulmonary post-mortem findings in a series of COVID-19 cases from northern Italy: a two-centre descriptive study. Lancet Infect Dis. 2020;20(10):1135\u201340. https:\/\/doi.org\/10.1016\/S1473-3099(20)30434-5.","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"5115_CR18","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1042\/CS20210879","volume":"136","author":"ME Long","year":"2022","unstructured":"Long ME, Mallampalli RK, Horowitz JC. Pathogenesis of pneumonia and acute lung injury. Clin Sci. 2022;136(10):747\u201369. https:\/\/doi.org\/10.1042\/CS20210879.","journal-title":"Clin Sci"},{"issue":"2","key":"5115_CR19","doi-asserted-by":"publisher","first-page":"e003150","DOI":"10.1136\/rmdopen-2023-003150","volume":"9","author":"X Chen","year":"2023","unstructured":"Chen X, Jiang W, Jin Q, Peng Q, Zhang L, Lin S, et al. Clinical, radiological and pathological features of anti-MDA5 antibody-associated interstitial lung disease. Rmd Open. 2023;9(2):e003150. https:\/\/doi.org\/10.1136\/rmdopen-2023-003150.","journal-title":"Rmd Open"},{"issue":"1","key":"5115_CR20","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s13054-015-0949-y","volume":"19","author":"KC Kao","year":"2015","unstructured":"Kao KC, Hu HC, Chang CH, Hung CY, Chiu LC, Li SH, et al. Diffuse alveolar damage associated mortality in selected acute respiratory distress syndrome patients with open lung biopsy. Crit Care. 2015;19(1):228. https:\/\/doi.org\/10.1186\/s13054-015-0949-y.","journal-title":"Crit Care"},{"issue":"10247","key":"5115_CR21","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1016\/S0140-6736(20)31305-2","volume":"396","author":"BT Bradley","year":"2020","unstructured":"Bradley BT, Maioli H, Johnston R, Chaudhry I, Fink SL, Xu H, et al. Histopathology and ultrastructural findings of fatal COVID-19 infections in washington state: A case series. Lancet Lond Engl. 2020;396(10247):320\u201332. https:\/\/doi.org\/10.1016\/S0140-6736(20)31305-2 . PubMed PMID: 32682491; PubMed Central PMCID: PMC7365650.","journal-title":"Lancet Lond Engl"},{"issue":"4","key":"5115_CR22","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/his.14180","volume":"77","author":"KE Konopka","year":"2020","unstructured":"Konopka KE, Nguyen T, Jentzen JM, Rayes O, Schmidt CJ, Wilson AM, et al. Diffuse alveolar damage (DAD) resulting from coronavirus disease 2019 infection is morphologically indistinguishable from other causes of DAD. Histopathology. 2020;77(4):570\u20138. https:\/\/doi.org\/10.1111\/his.14180.","journal-title":"Histopathology"},{"issue":"5","key":"5115_CR23","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1093\/rheumatology\/keu385","volume":"54","author":"N Kobayashi","year":"2015","unstructured":"Kobayashi N, Takezaki S, Kobayashi I, Iwata N, Mori M, Nagai K, et al. Clinical and laboratory features of fatal rapidly progressive interstitial lung disease associated with juvenile dermatomyositis. Rheumatology. 2015;54(5):784\u201391. https:\/\/doi.org\/10.1093\/rheumatology\/keu385.","journal-title":"Rheumatology"},{"issue":"5","key":"5115_CR24","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1165\/rcmb.2014-0089PS","volume":"50","author":"Z Borok","year":"2014","unstructured":"Borok Z. Alveolar epithelium: beyond the barrier. Am J Respir Cell Mol Biol. 2014;50(5):853\u20136. https:\/\/doi.org\/10.1165\/rcmb.2014-0089PS.","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"1","key":"5115_CR25","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1146\/annurev-physiol-030212-183756","volume":"75","author":"J Bhattacharya","year":"2013","unstructured":"Bhattacharya J, Matthay MA. Regulation and repair of the alveolar-capillary barrier in acute lung injury. Annu Rev Physiol. 2013;75(1):593\u2013615. https:\/\/doi.org\/10.1146\/annurev-physiol-030212-183756.","journal-title":"Annu Rev Physiol"},{"issue":"2","key":"5115_CR26","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1056\/NEJMoa2015432","volume":"383","author":"M Ackermann","year":"2020","unstructured":"Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19. N Engl J Med. 2020;383(2):120\u20138. https:\/\/doi.org\/10.1056\/NEJMoa2015432.","journal-title":"N Engl J Med"},{"issue":"3","key":"5115_CR27","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.stem.2020.06.020","volume":"27","author":"J Choi","year":"2020","unstructured":"Choi J, Park JE, Tsagkogeorga G, Yanagita M, Koo BK, Han N, et al. Inflammatory signals induce AT2 cell-derived damage-associated transient progenitors that mediate alveolar regeneration. Cell Stem Cell. 2020;27(3):366\u2013e3827. https:\/\/doi.org\/10.1016\/j.stem.2020.06.020 . PubMed PMID: 32750316; PubMed Central PMCID: PMC7487779.","journal-title":"Cell Stem Cell"},{"issue":"3","key":"5115_CR28","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/imm.13143","volume":"159","author":"A Ardain","year":"2020","unstructured":"Ardain A, Marakalala MJ, Leslie A. Tissue-resident innate immunity in the lung. Immunology. 2020;159(3):245\u201356. https:\/\/doi.org\/10.1111\/imm.13143.","journal-title":"Immunology"},{"issue":"55","key":"5115_CR29","doi-asserted-by":"publisher","first-page":"eabb6808","DOI":"10.1126\/sciimmunol.abb6808","volume":"6","author":"N Swarnalekha","year":"2021","unstructured":"Swarnalekha N, Schreiner D, Litzler LC, Iftikhar S, Kirchmeier D, K\u00fcnzli M, et al. T resident helper cells promote humoral responses in the lung. Sci Immunol. 2021;6(55):eabb6808. https:\/\/doi.org\/10.1126\/sciimmunol.abb6808.","journal-title":"Sci Immunol"},{"issue":"1","key":"5115_CR30","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1186\/s13287-020-01849-7","volume":"11","author":"M Kavianpour","year":"2020","unstructured":"Kavianpour M, Saleh M, Verdi J. The role of mesenchymal stromal cells in immune modulation of COVID-19: Focus on cytokine storm. Stem Cell Res Ther. 2020;11(1):404. https:\/\/doi.org\/10.1186\/s13287-020-01849-7.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"5115_CR31","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s41392-025-02178-y","volume":"10","author":"J Nie","year":"2025","unstructured":"Nie J, Zhou L, Tian W, Liu X, Yang L, Yang X, et al. Deep insight into cytokine storm: from pathogenesis to treatment. Signal Transduct Target Ther. 2025;10(1):112. https:\/\/doi.org\/10.1038\/s41392-025-02178-y.","journal-title":"Signal Transduct Target Ther"},{"key":"5115_CR32","doi-asserted-by":"publisher","DOI":"10.1093\/procel\/pwaf070","author":"D Su","year":"2025","unstructured":"Su D, Deng M, Hu L, Xie H, Yang B, Yang H, et al. A cell differentiation landscape for monocyte and interstitial macrophage in the lung with diffuse alveolar damage. Protein Cell. 2025. https:\/\/doi.org\/10.1093\/procel\/pwaf070.","journal-title":"Protein Cell"},{"key":"5115_CR33","doi-asserted-by":"publisher","first-page":"104945","DOI":"10.1016\/j.ebiom.2023.104945","volume":"99","author":"L Milross","year":"2024","unstructured":"Milross L, Hunter B, McDonald D, Merces G, Thomson A, Hilkens CMU, et al. Distinct lung cell signatures define the temporal evolution of diffuse alveolar damage in fatal COVID-19. Ebiomedicine. 2024;99:104945. https:\/\/doi.org\/10.1016\/j.ebiom.2023.104945.","journal-title":"Ebiomedicine"},{"issue":"1","key":"5115_CR34","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1146\/annurev-pathmechdis-031621-024344","volume":"18","author":"JD Planer","year":"2023","unstructured":"Planer JD, Morrisey EE. After the storm: regeneration, repair, and reestablishment of homeostasis between the alveolar epithelium and innate immune system following viral lung injury. Annu Rev Pathol Mech Dis. 2023;18(1):337\u201359. https:\/\/doi.org\/10.1146\/annurev-pathmechdis-031621-024344.","journal-title":"Annu Rev Pathol Mech Dis"},{"key":"5115_CR35","doi-asserted-by":"publisher","first-page":"173090","DOI":"10.1016\/j.ejphar.2020.173090","volume":"877","author":"C Yunna","year":"2020","unstructured":"Yunna C, Mengru H, Lei W, Weidong C. Macrophage M1\/M2 polarization. Eur J Pharmacol. 2020;877:173090. https:\/\/doi.org\/10.1016\/j.ejphar.2020.173090.","journal-title":"Eur J Pharmacol"},{"issue":"6727","key":"5115_CR36","doi-asserted-by":"publisher","first-page":"eado5561","DOI":"10.1126\/science.ado5561","volume":"386","author":"DL Jones","year":"2024","unstructured":"Jones DL, Morley MP, Li X, Ying Y, Zhao G, Schaefer SE, et al. An injury-induced mesenchymal-epithelial cell niche coordinates regenerative responses in the lung. Science. 2024;386(6727):eado5561. https:\/\/doi.org\/10.1126\/science.ado5561.","journal-title":"Science"},{"issue":"7","key":"5115_CR37","doi-asserted-by":"publisher","first-page":"3025","DOI":"10.1172\/JCI68782","volume":"123","author":"CE Barkauskas","year":"2013","unstructured":"Barkauskas CE, Cronce MJ, Rackley CR, Bowie EJ, Keene DR, Stripp BR, et al. Type 2 alveolar cells are stem cells in adult lung. J Clin Invest. 2013;123(7):3025\u201336. https:\/\/doi.org\/10.1172\/JCI68782.","journal-title":"J Clin Invest"},{"key":"5115_CR38","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1038\/s41584-019-0322-7","volume":"15","author":"JHW Distler","year":"2019","unstructured":"Distler JHW, Gy\u00f6rfi AH, Ramanujam M. Shared and distinct mechanisms of fibrosis. Nat Reviews Rheumatology; 705 Located at. 2019;15:705\u201330.","journal-title":"Nat Reviews Rheumatology; 705 Located at"},{"issue":"5","key":"5115_CR39","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1038\/ki.1997.192","volume":"51","author":"P Pintavorn","year":"1997","unstructured":"Pintavorn P, Ballermann BJ. TGF-\u03b2 and the endothelium during immune injury. Kidney Int. 1997;51(5):1401\u201312. https:\/\/doi.org\/10.1038\/ki.1997.192.","journal-title":"Kidney Int"},{"issue":"14","key":"5115_CR40","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.1016\/j.cell.2024.05.015","volume":"187","author":"M Kamiya","year":"2024","unstructured":"Kamiya M, Carter H, Espindola MS, Doyle TJ, Lee JS, Merriam LT, et al. Immune mechanisms in fibrotic interstitial lung disease. Cell. 2024;187(14):3506\u201330. https:\/\/doi.org\/10.1016\/j.cell.2024.05.015.","journal-title":"Cell"},{"issue":"2","key":"5115_CR41","doi-asserted-by":"publisher","first-page":"e12404","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh JA, Goberdhan DCI, O\u2019Driscoll L, Buzas EI, Blenkiron C, Bussolati B, et al. Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles. 2024;13(2):e12404. https:\/\/doi.org\/10.1002\/jev2.12404.","journal-title":"J Extracell Vesicles"},{"key":"5115_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/1478-811X-9-12","author":"R Hass","year":"2011","unstructured":"Hass R, Kasper C, B\u00f6hm S, Jacobs R. Different populations and sources of human mesenchymal stem cells (MSC): a comparison of adult and neonatal tissue-derived MSC. Cell Commun Signal. 2011. https:\/\/doi.org\/10.1186\/1478-811X-9-12.","journal-title":"Cell Commun Signal"},{"issue":"6","key":"5115_CR43","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s12015-017-9759-8","volume":"13","author":"D Macrin","year":"2017","unstructured":"Macrin D, Joseph JP, Pillai AA, Devi A. Eminent sources of adult mesenchymal stem cells and their therapeutic imminence. Stem Cell Rev Rep. 2017;13(6):741\u201356. https:\/\/doi.org\/10.1007\/s12015-017-9759-8.","journal-title":"Stem Cell Rev Rep"},{"issue":"3","key":"5115_CR44","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nbt.2816","volume":"32","author":"JA Ankrum","year":"2014","unstructured":"Ankrum JA, Ong JF, Karp JM. Mesenchymal stem cells: immune evasive, not immune privileged. Nat Biotechnol. 2014;32(3):252\u201360. https:\/\/doi.org\/10.1038\/nbt.2816.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"5115_CR45","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40364-019-0156-0","volume":"7","author":"P Lai","year":"2019","unstructured":"Lai P, Weng J, Guo L, Chen X, Du X. Novel insights into MSC-EVs therapy for immune diseases. Biomark Res. 2019;7(1):6. https:\/\/doi.org\/10.1186\/s40364-019-0156-0.","journal-title":"Biomark Res"},{"issue":"12","key":"5115_CR46","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.3390\/cells8121605","volume":"8","author":"CR Harrell","year":"2019","unstructured":"Harrell CR, Jovicic N, Djonov V, Arsenijevic N, Volarevic V. Mesenchymal stem cell-derived exosomes and other extracellular vesicles as new remedies in the therapy of inflammatory diseases. Cells. 2019;8(12):1605. https:\/\/doi.org\/10.3390\/cells8121605.","journal-title":"Cells"},{"key":"5115_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/nrm.2017.125","author":"G van Niel","year":"2017","unstructured":"van Niel G. Shedding light on the cell biology of extracellular vesicles. Nat Rev Mol Cell Biol. 2017. https:\/\/doi.org\/10.1038\/nrm.2017.125.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"5","key":"5115_CR48","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1016\/j.ymthe.2023.01.021","volume":"31","author":"R Cecchin","year":"2023","unstructured":"Cecchin R, Troyer Z, Witwer K, Morris KV. Extracellular vesicles: the next generation in gene therapy delivery. Mol Ther. 2023;31(5):1225\u201330. https:\/\/doi.org\/10.1016\/j.ymthe.2023.01.021.","journal-title":"Mol Ther"},{"issue":"5","key":"5115_CR49","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1089\/scd.2008.0253","volume":"18","author":"UM Fischer","year":"2009","unstructured":"Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, Savitz SI, et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev. 2009;18(5):683\u201392. https:\/\/doi.org\/10.1089\/scd.2008.0253.","journal-title":"Stem Cells Dev"},{"issue":"1","key":"5115_CR50","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/s13287-015-0271-2","volume":"7","author":"J Leibacher","year":"2016","unstructured":"Leibacher J, Henschler R. Biodistribution, migration and homing of systemically applied mesenchymal stem\/stromal cells. Stem Cell Res Ther. 2016;7(1):7. https:\/\/doi.org\/10.1186\/s13287-015-0271-2.","journal-title":"Stem Cell Res Ther"},{"key":"5115_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/264260","volume":"2013","author":"T Asami","year":"2013","unstructured":"Asami T, Ishii M, Fujii H, Namkoong H, Tasaka S, Matsushita K, et al. Modulation of murine macrophage TLR7\/8-mediated cytokine expression by mesenchymal stem cell-conditioned medium. Mediators Inflamm. 2013;2013:1\u201313. https:\/\/doi.org\/10.1155\/2013\/264260.","journal-title":"Mediators Inflamm"},{"issue":"10","key":"5115_CR52","doi-asserted-by":"publisher","first-page":"5295","DOI":"10.3390\/ijms23105295","volume":"23","author":"KH Wu","year":"2022","unstructured":"Wu KH, Li JP, Chao WR, Lee YJ, Yang SF, Cheng CC, et al. Immunomodulation via MyD88-NF\u03baB signaling pathway from human umbilical cord-derived mesenchymal stem cells in acute lung injury. Int J Mol Sci. 2022;23(10):5295. https:\/\/doi.org\/10.3390\/ijms23105295.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5115_CR53","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/s12890-020-01232-5","volume":"20","author":"L Zhang","year":"2020","unstructured":"Zhang L, Wang Y, Shen H, Zhao M. Combined signaling of NF-kappaB and IL-17 contributes to mesenchymal stem cells-mediated protection for paraquat-induced acute lung injury. Bmc Pulm Med. 2020;20(1):195. https:\/\/doi.org\/10.1186\/s12890-020-01232-5.","journal-title":"Bmc Pulm Med"},{"key":"5115_CR54","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.ebiom.2019.06.016","volume":"45","author":"Z Zhang","year":"2019","unstructured":"Zhang Z, Huang S, Wu S, Qi J, Li W, Liu S, et al. Clearance of apoptotic cells by mesenchymal stem cells contributes to immunosuppression via PGE2. Ebiomedicine. 2019;45:341\u201350. https:\/\/doi.org\/10.1016\/j.ebiom.2019.06.016.","journal-title":"Ebiomedicine"},{"issue":"2","key":"5115_CR55","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3390\/biomedicines11020445","volume":"11","author":"A Kulesza","year":"2023","unstructured":"Kulesza A, Paczek L, Burdzinska A. The role of COX-2 and PGE2 in the regulation of immunomodulation and other functions of mesenchymal stromal cells. Biomedicines. 2023;11(2):445. https:\/\/doi.org\/10.3390\/biomedicines11020445.","journal-title":"Biomedicines"},{"issue":"10","key":"5115_CR56","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1038\/s41419-020-03036-1","volume":"11","author":"J Zhu","year":"2020","unstructured":"Zhu J, Feng B, Xu Y, Chen W, Sheng X, Feng X, et al. Mesenchymal stem cells alleviate LPS-induced acute lung injury by inhibiting the proinflammatory function of Ly6C+ CD8\u2009+\u2009T cells. Cell Death Dis. 2020;11(10):829. https:\/\/doi.org\/10.1038\/s41419-020-03036-1.","journal-title":"Cell Death Dis"},{"issue":"1","key":"5115_CR57","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13287-025-04232-6","volume":"16","author":"C Xue","year":"2025","unstructured":"Xue C, Liu W, Li Y, Yin Y, Tang B, Zhu J, et al. Mesenchymal stem cells alleviate idiopathic pneumonia syndrome by facilitating M2 polarization via CCL2\/CCR2 axis and further inducing formation of regulatory CCR2\u2009+\u2009CD4\u2009+\u2009T cells. Stem Cell Res Ther. 2025;16(1):108. https:\/\/doi.org\/10.1186\/s13287-025-04232-6.","journal-title":"Stem Cell Res Ther"},{"key":"5115_CR58","doi-asserted-by":"publisher","DOI":"10.4097\/kja.25037","author":"CW Chuang","year":"2025","unstructured":"Chuang CW, Vo HPN, Huang YH, Tsai IL, Chang CY, Huang CJ. Human placental mesenchymal stem cell-derived exosomes carrying hsa-let-7i-5p mitigate lung injury in a murine model of aspiration pneumonia. Korean J Anesthesiol. 2025. https:\/\/doi.org\/10.4097\/kja.25037.","journal-title":"Korean J Anesthesiol"},{"issue":"1","key":"5115_CR59","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1186\/s12951-023-02038-3","volume":"21","author":"J Chen","year":"2023","unstructured":"Chen J, Ma S, Luo B, Hao H, Li Y, Yang H, et al. Human umbilical cord mesenchymal stromal cell small extracellular vesicle transfer of microRNA-223-3p to lung epithelial cells attenuates inflammation in acute lung injury in mice. J Nanobiotechnol. 2023;21(1):295. https:\/\/doi.org\/10.1186\/s12951-023-02038-3.","journal-title":"J Nanobiotechnol"},{"issue":"6","key":"5115_CR60","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1136\/thoraxjnl-2021-218194","volume":"78","author":"Y Su","year":"2023","unstructured":"Su Y, Silva JD, Doherty D, Simpson DA, Weiss DJ, Rolandsson-Enes S, et al. Mesenchymal stromal cells-derived extracellular vesicles reprogramme macrophages in ARDS models through the miR-181a-5p-PTEN-pSTAT5-SOCS1 axis. Thorax. 2023;78(6):617\u201330. https:\/\/doi.org\/10.1136\/thoraxjnl-2021-218194.","journal-title":"Thorax"},{"issue":"8","key":"5115_CR61","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41419-020-02857-4","volume":"11","author":"X Wei","year":"2020","unstructured":"Wei X, Yi X, Lv H, Sui X, Lu P, Li L, et al. MicroRNA-377-3p released by mesenchymal stem cell exosomes ameliorates lipopolysaccharide-induced acute lung injury by targeting RPTOR to induce autophagy. Cell Death Dis. 2020;11(8):657. https:\/\/doi.org\/10.1038\/s41419-020-02857-4.","journal-title":"Cell Death Dis"},{"key":"5115_CR62","doi-asserted-by":"publisher","first-page":"114537","DOI":"10.1016\/j.ecoenv.2023.114537","volume":"251","author":"L Hou","year":"2023","unstructured":"Hou L, Zhu Z, Jiang F, Zhao J, Jia Q, Jiang Q, et al. Human umbilical cord mesenchymal stem cell-derived extracellular vesicles alleviated silica induced lung inflammation and fibrosis in mice via circPWWP2A\/miR-223\u20133p\/NLRP3 axis. Ecotoxicol Environ Saf. 2023;251:114537. https:\/\/doi.org\/10.1016\/j.ecoenv.2023.114537.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"2","key":"5115_CR63","doi-asserted-by":"publisher","first-page":"130","DOI":"10.4274\/balkanmedj.galenos.2021.2021-9-8","volume":"39","author":"H Xu","year":"2021","unstructured":"Xu H, Nie G, Yin T, Shao C, Ding D, Zou M. Umbilical cord-derived mesenchymal stem cells with surfactant protein B alleviates inflammatory response in acute respiratory distress syndrome by regulating macrophage polarization. Balk Med J. 2021;39(2):130\u20139. https:\/\/doi.org\/10.4274\/balkanmedj.galenos.2021.2021-9-8.","journal-title":"Balk Med J"},{"key":"5115_CR64","doi-asserted-by":"publisher","first-page":"176380","DOI":"10.1016\/j.ejphar.2024.176380","volume":"967","author":"H Yang","year":"2024","unstructured":"Yang H, Liu Y, Yao J, Wang Y, Wang L, Ren P, et al. Mesenchymal stem cells inhibit ferroptosis by activating the Nrf2 antioxidation pathway in severe acute pancreatitis-associated acute lung injury. Eur J Pharmacol. 2024;967:176380. https:\/\/doi.org\/10.1016\/j.ejphar.2024.176380.","journal-title":"Eur J Pharmacol"},{"issue":"1","key":"5115_CR65","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s13287-015-0257-0","volume":"6","author":"Y Yang","year":"2015","unstructured":"Yang Y, Chen QH, Liu AR, Xu XP, Han JB, Qiu HB. Synergism of MSC-secreted HGF and VEGF in stabilising endothelial barrier function upon lipopolysaccharide stimulation via the Rac1 pathway. Stem Cell Res Ther. 2015;6(1):250. https:\/\/doi.org\/10.1186\/s13287-015-0257-0.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"5115_CR66","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s11658-025-00757-z","volume":"30","author":"S Xin","year":"2025","unstructured":"Xin S, Ding Y, Yu T, Fu Y, Cui Y, Nie H. Mesenchymal stem cell-secreted KGF ameliorates acute lung injury via the Gab1\/ERK\/NF-\u03baB signaling axis. Cell Mol Biol Lett. 2025;30(1):79. https:\/\/doi.org\/10.1186\/s11658-025-00757-z.","journal-title":"Cell Mol Biol Lett"},{"issue":"9","key":"5115_CR67","doi-asserted-by":"publisher","first-page":"e269","DOI":"10.1371\/journal.pmed.0040269","volume":"4","author":"SHJ Mei","year":"2007","unstructured":"Mei SHJ, McCarter SD, Deng Y, Parker CH, Liles WC, Stewart DJ. Prevention of LPS-induced acute lung injury in mice by mesenchymal stem cells overexpressing angiopoietin 1. PLoS Med. 2007;4(9):e269. https:\/\/doi.org\/10.1371\/journal.pmed.0040269.","journal-title":"PLoS Med"},{"issue":"10","key":"5115_CR68","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1164\/rccm.201701-0170OC","volume":"196","author":"TJ Morrison","year":"2017","unstructured":"Morrison TJ, Jackson MV, Cunningham EK, Kissenpfennig A, McAuley DF, O\u2019Kane CM, et al. Mesenchymal stromal cells modulate macrophages in clinically relevant lung injury models by extracellular vesicle mitochondrial transfer. Am J Respir Crit Care Med. 2017;196(10):1275\u201386. https:\/\/doi.org\/10.1164\/rccm.201701-0170OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"5115_CR69","doi-asserted-by":"publisher","first-page":"2474897","DOI":"10.1080\/13510002.2025.2474897","volume":"30","author":"J Wang","year":"2025","unstructured":"Wang J, Meng S, Chen Y, Wang H, Hu W, Liu S, et al. MSC-mediated mitochondrial transfer promotes metabolic reprograming in endothelial cells and vascular regeneration in ARDS. Redox Rep. 2025;30(1):2474897. https:\/\/doi.org\/10.1080\/13510002.2025.2474897.","journal-title":"Redox Rep"},{"issue":"10","key":"5115_CR70","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1038\/s41419-020-03034-3","volume":"11","author":"K Xiao","year":"2020","unstructured":"Xiao K, He W, Guan W, Hou F, Yan P, Xu J, et al. Mesenchymal stem cells reverse EMT process through blocking the activation of NF-\u03baB and hedgehog pathways in LPS-induced acute lung injury. Cell Death Dis. 2020;11(10):863. https:\/\/doi.org\/10.1038\/s41419-020-03034-3.","journal-title":"Cell Death Dis"},{"key":"5115_CR71","doi-asserted-by":"publisher","first-page":"237","DOI":"10.2147\/DDDT.S344309","volume":"16","author":"X Zhang","year":"2022","unstructured":"Zhang X, Ye L, Tang W, Ji Y, Zheng L, Chen Y, et al. Wnt\/\u03b2-catenin participates in the repair of acute respiratory distress syndrome-associated early pulmonary fibrosis via mesenchymal stem cell microvesicles. Drug Des Devel Ther. 2022;16:237\u201347. https:\/\/doi.org\/10.2147\/DDDT.S344309.","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"5115_CR72","doi-asserted-by":"publisher","first-page":"2004216","DOI":"10.1183\/13993003.04216-2020","volume":"59","author":"CC Dos Santos","year":"2022","unstructured":"Dos Santos CC, Amatullah H, Vaswani CM, Maron-Gutierrez T, Kim M, Mei SHJ, et al. Mesenchymal stromal (stem) cell therapy modulates miR-193b-5p expression to attenuate sepsis-induced acute lung injury. Eur Respir J. 2022;59(1):2004216. https:\/\/doi.org\/10.1183\/13993003.04216-2020.","journal-title":"Eur Respir J"},{"issue":"1","key":"5115_CR73","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s10020-023-00630-9","volume":"29","author":"R Xu","year":"2023","unstructured":"Xu R, Wu M, Wang Y, Li C, Zeng L, Wang Y, et al. Mesenchymal stem cells reversibly de-differentiate myofibroblasts to fibroblast-like cells by inhibiting the TGF-\u03b2-SMAD2\/3 pathway. Mol Med. 2023;29(1):59. https:\/\/doi.org\/10.1186\/s10020-023-00630-9.","journal-title":"Mol Med"},{"issue":"1","key":"5115_CR74","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12951-025-03312-2","volume":"23","author":"WJ Gu","year":"2025","unstructured":"Gu WJ, Zhao FZ, Huang W, Zhu MG, Huang HY, Yin HY, et al. Selenium nanoparticles activate selenoproteins to mitigate septic lung injury through miR-20b-mediated ROR\u03b3t\/STAT3\/Th17 axis inhibition and enhanced mitochondrial transfer in BMSCs. J Nanobiotechnol. 2025;23(1):226. https:\/\/doi.org\/10.1186\/s12951-025-03312-2.","journal-title":"J Nanobiotechnol"},{"issue":"1","key":"5115_CR75","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/s13287-025-04266-w","volume":"16","author":"X Liang","year":"2025","unstructured":"Liang X, Li Y, Wu Y, Wu T, Huang D, Tang Z, et al. Human umbilical cord mesenchymal stem cell-derived microvesicles alleviate pulmonary fibrosis by inhibiting monocyte\u2013macrophage migration through ERK1\/2 signaling-mediated suppression of CCL2 expression. Stem Cell Res Ther. 2025;16(1):145. https:\/\/doi.org\/10.1186\/s13287-025-04266-w.","journal-title":"Stem Cell Res Ther"},{"issue":"6","key":"5115_CR76","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.chest.2023.06.024","volume":"164","author":"AL Lightner","year":"2023","unstructured":"Lightner AL, Sengupta V, Qian S, Ransom JT, Suzuki S, Park DJ, et al. Bone marrow mesenchymal stem cell-derived extracellular vesicle infusion for the treatment of respiratory failure from COVID-19. Chest. 2023;164(6):1444\u201353. https:\/\/doi.org\/10.1016\/j.chest.2023.06.024.","journal-title":"Chest"},{"issue":"9","key":"5115_CR77","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/s41422-020-0354-1","volume":"30","author":"J Wu","year":"2020","unstructured":"Wu J, Song D, Li Z, Guo B, Xiao Y, Liu W, et al. Immunity-and-matrix-regulatory cells derived from human embryonic stem cells safely and effectively treat mouse lung injury and fibrosis. Cell Res. 2020;30(9):794\u2013809. https:\/\/doi.org\/10.1038\/s41422-020-0354-1.","journal-title":"Cell Res"},{"issue":"23","key":"5115_CR78","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.3390\/cells12232729","volume":"12","author":"P Valiukevi\u010dius","year":"2023","unstructured":"Valiukevi\u010dius P, Ma\u010diulaitis J, Pangonyt\u0117 D, Siratavi\u010di\u016bt\u0117 V, Kluszczy\u0144ska K, Kuzaityt\u0117 U, et al. Human placental mesenchymal stem cells and derived extracellular vesicles ameliorate lung injury in acute respiratory distress syndrome murine model. Cells. 2023;12(23):2729. https:\/\/doi.org\/10.3390\/cells12232729.","journal-title":"Cells"},{"issue":"1","key":"5115_CR79","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13287-025-04203-x","volume":"16","author":"Y Wang","year":"2025","unstructured":"Wang Y, Ding H, Bai R, Li Q, Ren B, Lin P, et al. Exosomes from adipose-derived stem cells accelerate wound healing by increasing the release of IL-33 from macrophages. Stem Cell Res Ther. 2025;16(1):80. https:\/\/doi.org\/10.1186\/s13287-025-04203-x.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"5115_CR80","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s13287-025-04388-1","volume":"16","author":"T Ruan","year":"2025","unstructured":"Ruan T, Han J, Xue C, Wang F, Lin J. Mesenchymal stem cells protect the integrity of the alveolar epithelial barrier through extracellular vesicles by inhibiting MAPK-mediated necroptosis. Stem Cell Res Ther. 2025;16(1):250. https:\/\/doi.org\/10.1186\/s13287-025-04388-1.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"5115_CR81","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3390\/ijms26010075","volume":"26","author":"RP Thiruvenkataramani","year":"2024","unstructured":"Thiruvenkataramani RP, Abdul-Hafez A, Kesaraju T, Mohamed H, Ibrahim SA, Othman A, et al. Small extracellular vesicles derived from cord blood plasma and placental mesenchymal stem cells attenuate acute lung injury induced by lipopolysaccharide (LPS). Int J Mol Sci. 2024;26(1):75. https:\/\/doi.org\/10.3390\/ijms26010075.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"5115_CR82","doi-asserted-by":"publisher","first-page":"e12495","DOI":"10.1002\/jev2.12495","volume":"13","author":"JH Lee","year":"2024","unstructured":"Lee JH, Jeon H, L\u00f6tvall J, Cho BS. Therapeutic potential of mesenchymal stem cell-derived extracellular vesicles in SARS\u2010CoV\u20102 and H1N1 influenza\u2010induced acute lung injury. J Extracell Vesicles. 2024;13(9):e12495. https:\/\/doi.org\/10.1002\/jev2.12495.","journal-title":"J Extracell Vesicles"},{"issue":"12","key":"5115_CR83","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1164\/rccm.202305-0865OC","volume":"208","author":"AI Batchinsky","year":"2023","unstructured":"Batchinsky AI, Roberts TR, Antebi B, Necsoiu C, Choi JH, Herzig M, et al. Intravenous autologous bone marrow\u2013derived mesenchymal stromal cells delay acute respiratory distress syndrome in swine. Am J Respir Crit Care Med. 2023;208(12):1283\u201392. https:\/\/doi.org\/10.1164\/rccm.202305-0865OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"5115_CR84","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1186\/s13287-021-02245-5","volume":"12","author":"M Florian","year":"2021","unstructured":"Florian M, Wang JP, Deng Y, Souza-Moreira L, Stewart DJ, Mei SHJ. Gene engineered mesenchymal stem cells: greater transgene expression and efficacy with minicircle vs. plasmid DNA vectors in a mouse model of acute lung injury. Stem Cell Res Ther. 2021;12(1):184. https:\/\/doi.org\/10.1186\/s13287-021-02245-5.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"5115_CR85","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1186\/s13287-024-03977-w","volume":"15","author":"S Regmi","year":"2024","unstructured":"Regmi S, Ganguly A, Pathak S, Primavera R, Chetty S, Wang J, et al. Evaluating the therapeutic potential of different sources of mesenchymal stem cells in acute respiratory distress syndrome. Stem Cell Res Ther. 2024;15(1):385. https:\/\/doi.org\/10.1186\/s13287-024-03977-w.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"5115_CR86","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/s13287-025-04576-z","volume":"16","author":"J Jeong","year":"2025","unstructured":"Jeong J, Park JK, Shin J, Jung I, Kim HW, Park A, et al. Inflammatory cytokine-primed MSC-derived extracellular vesicles ameliorate acute lung injury via enhanced immunomodulation and alveolar repair. Stem Cell Res Ther. 2025;16(1):450. https:\/\/doi.org\/10.1186\/s13287-025-04576-z.","journal-title":"Stem Cell Res Ther"},{"issue":"10","key":"5115_CR87","doi-asserted-by":"publisher","first-page":"3422","DOI":"10.1016\/j.ymthe.2024.08.003","volume":"32","author":"C Tunstead","year":"2024","unstructured":"Tunstead C, Volkova E, Dunbar H, Hawthorne IJ, Bell A, Crowe L, et al. The ARDS microenvironment enhances MSC-induced repair via VEGF in experimental acute lung inflammation. Mol Ther. 2024;32(10):3422\u201332. https:\/\/doi.org\/10.1016\/j.ymthe.2024.08.003.","journal-title":"Mol Ther"},{"issue":"1","key":"5115_CR88","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/S2213-2600(14)70291-7","volume":"3","author":"JG Wilson","year":"2015","unstructured":"Wilson JG, Liu KD, Zhuo H, Caballero L, McMillan M, Fang X, et al. Mesenchymal stem (stromal) cells for treatment of ARDS: A phase 1 clinical trial. Lancet Respir Med. 2015;3(1):24\u201332. https:\/\/doi.org\/10.1016\/S2213-2600(14)70291-7.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"5115_CR89","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s13287-023-03402-8","volume":"14","author":"M Zarrabi","year":"2023","unstructured":"Zarrabi M, Shahrbaf MA, Nouri M, Shekari F, Hosseini SE, Hashemian SMR, et al. Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial. Stem Cell Res Ther. 2023;14(1):169. https:\/\/doi.org\/10.1186\/s13287-023-03402-8.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"5115_CR90","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s13287-022-02796-1","volume":"13","author":"CLK Rebelatto","year":"2022","unstructured":"Rebelatto CLK, Senegaglia AC, Franck CL, Daga DR, Shigunov P, Stimamiglio MA, et al. Safety and long-term improvement of mesenchymal stromal cell infusion in critically COVID-19 patients: a randomized clinical trial. Stem Cell Res Ther. 2022;13(1):122. https:\/\/doi.org\/10.1186\/s13287-022-02796-1.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"5115_CR91","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1186\/s13287-025-04597-8","volume":"16","author":"J Yuan","year":"2025","unstructured":"Yuan J, Yang YL, Zhao YL, Xu YW, Wang L, Gao JF. Advancements in mesenchymal stromal cells for treating connective tissue disease-associated interstitial lung disease: from basic research to clinical application. Stem Cell Res Ther. 2025;16(1):457. https:\/\/doi.org\/10.1186\/s13287-025-04597-8.","journal-title":"Stem Cell Res Ther"},{"key":"5115_CR92","doi-asserted-by":"publisher","DOI":"10.1155\/2023\/7179592","author":"PR Hsueh","year":"2023","unstructured":"Hsueh PR, Ho SJ, Hsieh PC, Liu IM, Jean SS. Use of multiple doses of intravenous infusion of umbilical cord-mesenchymal stem cells for the treatment of adult patients with severe COVID-19-related acute respiratory distress syndrome: Literature review. Stem Cells Int. 2023. https:\/\/doi.org\/10.1155\/2023\/7179592.","journal-title":"Stem Cells Int"},{"key":"5115_CR93","doi-asserted-by":"publisher","first-page":"1224865","DOI":"10.3389\/fmed.2023.1224865","volume":"10","author":"C Pochon","year":"2023","unstructured":"Pochon C, Laroye C, Kimmoun A, Reppel L, Dhuyser A, Rousseau H, et al. Efficacy of wharton jelly mesenchymal stromal cells infusions in moderate to severe SARS-cov-2 related acute respiratory distress syndrome: a phase 2a double-blind randomized controlled trial. Front Med. 2023;10:1224865. https:\/\/doi.org\/10.3389\/fmed.2023.1224865.","journal-title":"Front Med"},{"issue":"2","key":"5115_CR94","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1093\/rheumatology\/keae285","volume":"64","author":"R Zhou","year":"2025","unstructured":"Zhou R, Jin X, Li J, He Y, Gao T, Zhu C, et al. Human umbilical cord mesenchymal stem cells treated anti-MDA5 antibody-positive dermatomyositis with interstitial lung disease: a case report. Rheumatology. 2025;64(2):892\u20134. https:\/\/doi.org\/10.1093\/rheumatology\/keae285.","journal-title":"Rheumatology"},{"issue":"1","key":"5115_CR95","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s13287-021-02165-4","volume":"12","author":"SMR Hashemian","year":"2021","unstructured":"Hashemian SMR, Aliannejad R, Zarrabi M, Soleimani M, Vosough M, Hosseini SE, et al. Mesenchymal stem cells derived from perinatal tissues for treatment of critically ill COVID-19-induced ARDS patients: a case series. Stem Cell Res Ther. 2021;12(1):91. https:\/\/doi.org\/10.1186\/s13287-021-02165-4.","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"5115_CR96","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1002\/sctm.20-0472","volume":"10","author":"G Lanzoni","year":"2021","unstructured":"Lanzoni G, Linetsky E, Correa D, Messinger Cayetano S, Alvarez RA, Kouroupis D, et al. Umbilical cord mesenchymal stem cells for COVID-19 acute respiratory distress syndrome: a double-blind, phase 1\/2a, randomized controlled trial. Stem Cells Transl Med. 2021;10(5):660\u201373. https:\/\/doi.org\/10.1002\/sctm.20-0472.","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"5115_CR97","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13054-022-03930-4","volume":"26","author":"A Monsel","year":"2022","unstructured":"Monsel A, Hauw-Berlemont C, Mebarki M, Heming N, Mayaux J, Nguekap Tchoumba O, et al. Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial. Crit Care. 2022;26(1):48. https:\/\/doi.org\/10.1186\/s13054-022-03930-4.","journal-title":"Crit Care"},{"issue":"5","key":"5115_CR98","doi-asserted-by":"publisher","first-page":"4435","DOI":"10.3390\/ijms24054435","volume":"24","author":"T Bukreieva","year":"2023","unstructured":"Bukreieva T, Svitina H, Nikulina V, Vega A, Chybisov O, Shablii I, et al. Treatment of acute respiratory distress syndrome caused by COVID-19 with human umbilical cord mesenchymal stem cells. Int J Mol Sci. 2023;24(5):4435. https:\/\/doi.org\/10.3390\/ijms24054435.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5115_CR99","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s13287-023-03402-8","volume":"14","author":"M Zarrabi","year":"2023","unstructured":"Zarrabi M, Shahrbaf MA, Nouri M, Shekari F, Hosseini SE, Hashemian SMR, et al. Allogenic mesenchymal stromal cells and their extracellular vesicles in COVID-19 induced ARDS: a randomized controlled trial. Stem Cell Res Ther. 2023;14(1):169. https:\/\/doi.org\/10.1186\/s13287-023-03402-8.","journal-title":"Stem Cell Res Ther"},{"issue":"1","key":"5115_CR100","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s13287-024-03729-w","volume":"15","author":"A Sitbon","year":"2024","unstructured":"Sitbon A, Hauw-Berlemont C, Mebarki M, Heming N, Mayaux J, Diehl JL, et al. Treatment of COVID-19-associated ARDS with umbilical cord-derived mesenchymal stromal cells in the STROMA-CoV-2 multicenter randomized double-blind trial: long-term safety, respiratory function, and quality of life. Stem Cell Res Ther. 2024;15(1):109. https:\/\/doi.org\/10.1186\/s13287-024-03729-w.","journal-title":"Stem Cell Res Ther"},{"issue":"7","key":"5115_CR101","doi-asserted-by":"publisher","first-page":"e12492","DOI":"10.1002\/jev2.12492","volume":"13","author":"MH Zamanian","year":"2024","unstructured":"Zamanian MH, Norooznezhad AH, Hosseinkhani Z, Hassaninia D, Mansouri F, Vaziri S, et al. Human placental mesenchymal stromal cell-derived small extracellular vesicles as a treatment for severe COVID\u201019: a double\u2010blind randomized controlled clinical trial. J Extracell Vesicles. 2024;13(7):e12492. https:\/\/doi.org\/10.1002\/jev2.12492.","journal-title":"J Extracell Vesicles"},{"key":"5115_CR102","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-025-04148-1","author":"MQ Yuan","year":"2025","unstructured":"Yuan MQ, Song L, Zhang ZY. Long-term outcomes of mesenchymal stem cell therapy in severe COVID-19 patients_ 3-year follow-up of a randomized, double-blind, placebo-controlled trial. Stem Cell Res Ther. 2025. https:\/\/doi.org\/10.1186\/s13287-025-04148-1.","journal-title":"Stem Cell Res Ther"},{"issue":"9","key":"5115_CR103","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1016\/j.jcyt.2025.04.059","volume":"27","author":"R Tonelli","year":"2025","unstructured":"Tonelli R, Pischiutta F, Elice F, Zanier ER, Grisendi G, Astori G, et al. Impact of mesenchymal stromal\/stem cell infusions on circulating inflammatory biomarkers in COVID-19 patients: analysis of a phase I-IIa trial. Cytotherapy. 2025;27(9):1105\u201315. https:\/\/doi.org\/10.1016\/j.jcyt.2025.04.059.","journal-title":"Cytotherapy"}],"container-title":["Stem Cell Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13287-026-05115-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05115-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13287-026-05115-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T12:09:54Z","timestamp":1787573394000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13287-026-05115-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,15]]},"references-count":103,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5115"],"URL":"https:\/\/doi.org\/10.1186\/s13287-026-05115-0","relation":{},"ISSN":["1757-6512"],"issn-type":[{"value":"1757-6512","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,15]]},"assertion":[{"value":"9 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"291"}}